Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IVIg for severe COVID-19 not responding to standard three-drug protocol
IRCT20200325046859N1Phase 2Completed
- Sponsor
- Mashhad University of Medical Sciences
- Start
- Apr 2020
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, single-arm trial of immune globulin in coronavirus disease 2019 (COVID-19), sponsored by Mashhad University of Medical Sciences. Started Apr 2020; status: completed.
02
Drugs
immune globulin
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on IRCT20200325046859N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20200325046859N1.